newsfilter
← Latest News
GlobeNewswire·

Histogen Reports Second Quarter 2022 Financial Results and Provides Business Update

Closed $5M Financing in July Regained Compliance with Nasdaq Minimum Bid Price Requirement SAN DIEGO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ:HSTO), a clinical-stage therapeutics company focused on developing both restorative ther